World Health Organization

World Health Day 2017: Let’s talk about depression and TB

The prevalence of mental disorders among people with TB is estimated to be between 40-70%.

Read More →

Next-generation Xpert® MTB/RIF Ultra assay recommended by WHO

The World Health Organization (WHO) recommends the use of a next-generation Xpert® MTB/RIF assay (called Xpert® MTB/RIF Ultra) as a replacement for the current Xpert MTB/RIF® cartridge.

Read More →

WHO issues ethics guidance to protect rights of TB patients

World TB Day 2017 – Unite efforts to leave no one behind

Read More →

WHO maintains existing recommendations for the use of bedaquiline

The conditional recommendation will be maintained until a new systematic review of evidence is warranted or the results of the phase III clinical trial of bedaquiline become available.

Read More →

WHO stresses urgent need for R&D for drug-resistant TB alongside newly-prioritized antibiotic-resistant pathogens

28 February 2017 | GENEVA - WHO reaffirms the critical need for research and development (R&D) of new antibiotics to tackle the threat of drug-resistant tuberculosis (TB).

Read More →

WHO publishes list of bacteria for which new antibiotics are urgently needed

27 February 2017 | GENEVA WHO today published its first ever list of antibiotic-resistant "priority pathogens" – a catalogue of 12 families of bacteria that pose the greatest threat to human health.

Read More →

WHO survey: Values and preferences for the management of latent TB

The World Health Organization (WHO) is currently developing new guidelines on the management of latent TB infection. The issues covered by the guidelines will include provision of TB preventive treatment for people living with HIV and people who were exposed to a person with active TB disease at home and regimen of preventive TB treatment. 

Read More →

WHO establishes Global TB Research Task Force

Geneva, 21 December  2016 - In an effort to accelerate progress towards ending TB, WHO’s Global TB Programme (GTB)  has established the first Global TB Research Task Force.

Read More →

WHO: Technical assistance for the strengthening of childhood TB case finding and management in Liberia

The World Health Organization (WHO) is seeking a paediatrician with expertise in childhood tuberculosis (TB) for Liberia to facilitate (i) review of diagnostic practices in-country and confirmation of diagnostic algorithms; (ii) development of training materials on childhood TB and (iii) indicators for childhood TB case findings, treatment success and preventive chemotherapy (IPT) with annual targets up to 2020.

Read More →

WHO: The use of delamanid in the treatment of MDR-TB in children and adolescents: Interim policy guidance

Multidrug-resistant tuberculosis (MDR-TB) is a public health challenge of growing concern. Approximately 580 000 people acquired MDR-TB in 2015, with children accounting for close to 30 000 of MDR-TB cases.

Read More →

Page 1 of 8 · Total posts: 10

1 2 Last→